An miRNA signature associated with tumor mutation burden in endometrial cancer

Tumor mutation burden (TMB) is an essential biomarker to predict immunotherapy response. TMB measurement was mainly evaluated by whole-exome sequencing (WES), which was costly and difficult to be widely applied. In the present study, we aimed to establish and validate a miRNA signature to predict TM...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hongyu, Chen, Lihua, Qin, Mei, Lei, Yajie, Li, Tianjiao, Li, Haoran, Cheng, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670578/
https://www.ncbi.nlm.nih.gov/pubmed/33141168
http://dx.doi.org/10.1042/BSR20203398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670578/
https://www.ncbi.nlm.nih.gov/pubmed/33141168
http://dx.doi.org/10.1042/BSR20203398

Ejemplares similares